Remember that next Tuesday and Wednesday the FDA committee will hold its hearing to review the recent recommendation to rescind approval for Avastin® in treating metastatic breast cancer.
Here are previous posts on the topic.
- MBC patient’s husband gathers support for Avastin hearing
- Medicare continues to pay for Avastin pending hearing outcome
- FDA grants Avastin hearing 6/28-29/2011
- update: Avastin decision postponed
- Avastin again in news: fed ready to consider rescinding approval for MBC
- committee recommends Avastin approval be revoked for advanced breast cancer
- Avastin disapproved for breast cancer treatment
5 6 7 8
© 2004–2011 Donna Peach. All rights reserved.